US 9770450
4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139
granted A61KA61K31/53A61P
Quick answer
US patent 9770450 (4-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139) held by Takeda Pharmaceutical Company Limited expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/53, A61P, A61P21/00, A61P25/00